KMT2A and acute myeloid leukemia: KMT2A rearrangements in children with AML— including monocytic (FAB M5), myelomonocytic (FAB M4), and megakaryoblastic (FAB M7) subtypes—can affect the prognosis in different ways, depending on the specific partner gene.